Table 5. Leukocytosis and ORs for VTE among newly diagnosed lung cancer patients.
| Patients Group | Leukocytosis1 | OR(95%CI) |
||
|---|---|---|---|---|
| Number of patients (%) | Unadjusted | Adjusted2 | Adjusted3 | |
| No hypertension and no VTE | 63(13.6) | 1 | 1 | 1 |
| Only hypertension | 11(13.1) | 0.95(0.48–1.90) | 0.87(0.42–1.79) | 0.90(0.43–1.88) |
| Only VTE | 20(30.8) | 2.82(1.56–5.08) | 3.51(1.67–5.96) | 3.21(1.69–6.08) |
| Both hypertension and VTE | 4(19.0) | 1.49(0.49–4.57) | 1.33(0.41–4.39) | 1.33(0.41–4.36) |
| P for trend | 0.006 | 0.006 | 0.011 | 0.009 |
1Leukocytosis was defined as WBC count of at least 10 × 109/L.
2Adjusted for age, gender, smoking, body mass index, diabetes, dyslipidemia, and tumor histology (adenocarcinoma vs. non-adenocarcinoma).
3Adjusted for age, gender, smoking, body mass index, diabetes, dyslipidemia, and tumor stage (localized stage vs. distant metastasis).
Abbreviations: VTE = venous thromboembolism; OR = Odds Ratio; WBC = white blood cell.